Cardiology
RCT: similar outcomes in patients with heart failure with preserved ejection fraction randomized to high-intensity interval training vs. moderate continuous training vs. guideline-based physical activity advice
28 Feb, 2021 | 21:06h | UTCEffect of High-Intensity Interval Training, Moderate Continuous Training, or Guideline-Based Physical Activity Advice on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)
Commentary: Hold Off on HIIT for Patients with Heart Failure with Preserved EF – Physician’s Weekly
Commentary on Twitter
In this RCT, high-intensity interval training was no better at improving peak V̇O₂ at 3 months vs moderate continuous or guideline control training, in patients with #HFpEF https://t.co/CZzAcQESLg @TUMSportMedizin @jamacardiology @jamainternalmed #VisualAbstract
— JAMA Cardiology (@JAMACardio) February 22, 2021
Observational study suggests women have a lower range of ‘normal’ blood pressure than men
28 Feb, 2021 | 20:52h | UTCNews release: Women Have a Lower Range of ‘Normal’ Blood Pressure Than Men – Cedars-Sinai
Original study: Sex Differences in Blood Pressure Associations With Cardiovascular Outcomes – Circulation
Commentary: Women’s Risk for CVD Seen at Lower BP Thresholds Than Men – TCTMD
Commentary on Twitter
Sex differences in associations of systolic blood pressure with incident CVD: are sex-specific blood pressure goals needed? https://t.co/JibgGRh9uP #GoRedforWomen #AHAJournals @BP_Teemu pic.twitter.com/SWEWBjA2Nx
— Circulation (@CircAHA) February 17, 2021
Systematic Review: Cardiovascular Effects of Medical Marijuana
28 Feb, 2021 | 20:48h | UTCCardiovascular Effects of Medical Marijuana: A Systematic Review – The American Journal of Medicine
COVID-19 hospitalizations attributable to cardiometabolic conditions
26 Feb, 2021 | 08:40h | UTCCommentary: Study estimates two-thirds of COVID-19 hospitalizations due to four conditions – Tufts University
Commentary on Twitter
Our new research suggests 63% of US hospitalizations for COVID may have been prevented, due to less severe illness, if we had a metabolically healthy population. Biggest risk: obesity, responsible for 30% of excess hospitalizations. https://t.co/no8YhACf4E pic.twitter.com/4VPuHT0OPd
— Dariush Mozaffarian (@Dmozaffarian) February 25, 2021
Cohort study: A single conventional Troponin combined with HEART score may be as good as serial measurements for safe discharge of patients with chest pain in the ED
26 Feb, 2021 | 08:32h | UTCEditorial: Troponin Testing in the Emergency Department—When 2 Become 1
Commentary: Single Troponin Test May Be Enough for Safe Discharge of Chest Pain Patients – TCTMD
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
26 Feb, 2021 | 08:18h | UTCMyocarditis and inflammatory cardiomyopathy: current evidence and future directions – Nature Reviews Cardiology (free for a limited period)
Series of n-of-1 trials show no difference in muscle symptoms in patients receiving placebo or statins
25 Feb, 2021 | 08:54h | UTCCommentary: Do statins cause muscle symptom side effects? – The BMJ Opinion AND Study: Muscle Symptoms Didn’t Differ Between Statin and Placebo Periods – NEJM Journal Watch
Related study: #AHA20 – In patients who had discontinued statins because of side effects, a N-of-1 trial of a statin, placebo, or no treatment found that side effects often attributed to statins were the same for those taking a placebo (study and commentaries)
Cohort study: High glycemic index diets are linked to increased risk of cardiovascular disease and death
25 Feb, 2021 | 08:49h | UTCCommentaries: Study finds diet high in poor quality carbohydrates increases heart disease and death – McMaster University AND High Glycemic Index Diets Linked to CVD and Mortality – TCTMD
Collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals
25 Feb, 2021 | 08:25h | UTC
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease
24 Feb, 2021 | 02:21h | UTC
Commentary on Twitter (thread – Click for more)
The 2021 KDIGO guideline covers optimal BP targets in patients with CKD, proper BP measurement, lifestyle interventions, antihypertensive medications, and issues specific to management in kidney transplant recipients and children. https://t.co/OXfhCbBQS9
— Kathryn Foti (@fotikat) February 23, 2021
Physical Activity: what’s the latest guidance?
24 Feb, 2021 | 02:19h | UTCPhysical Activity: what’s the latest guidance? – Evidently Cochrane
See also: New WHO guidelines on physical activity and sedentary behavior – Every move counts towards better health (Guideline and commentaries)
Pro-con Debate: Starting antihypertensive drug treatment with combination therapy
23 Feb, 2021 | 01:26h | UTCCon: Starting Antihypertensive Drug Treatment With Combination Therapy
Pro: Starting Antihypertensive Drug Treatment With Combination Therapy
M-A: Blood pressure effects of sodium reduction
23 Feb, 2021 | 01:28h | UTCCommentaries: The Lower the Sodium, the Better for BP: Updated Meta-analysis – TCTMD AND AHA News: Lower Your Sodium, and Blood Pressure Will Follow – HealthDay
New insights into plaque erosion as a mechanism of acute coronary syndromes
23 Feb, 2021 | 01:20h | UTCNew Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes – JAMA
Author Interview: New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes – JAMA
Prevalence of bicuspid aortic valve and associated aortopathy in newborns in Copenhagen, Denmark
21 Feb, 2021 | 21:58h | UTCPrevalence of Bicuspid Aortic Valve and Associated Aortopathy in Newborns in Copenhagen, Denmark – JAMA (link to abstract – $ for full-text)
Commentary on Twitter
In this population epi study the prevalence of bicuspid aortic valve (BAV) among newborns in Copenhagen was 0.77%; aortopathy incl. coarctation was common, suggesting that it represents a fetal malformation https://t.co/xqUBzQn9NA @HenningBundgaa1 @jamapediatrics
— JAMA (@JAMA_current) February 11, 2021
Expert consensus of data elements for collection for enhanced recovery after cardiac surgery
21 Feb, 2021 | 21:53h | UTCRelated: Enhanced Recovery After Surgery (ERAS) Guidelines for Perioperative Care in Cardiac Surgery (guideline and commentary) AND Enhanced Recovery After Cardiac Surgery (ERAS Cardiac) Recommendations: An Important First Step—But There Is Much Work to Be Done – Cardiothoracic and Vascular Anesthesia (free)
See also: Enhanced Recovery After Surgery (ERAS) Society Guidelines
Commentary on Twitter
Just published in @WorldJSurg
"Expert Consensus of Data Elements for Collection for Enhanced Recovery After Cardiac Surgery"
Available for free download here https://t.co/7L4evdqg0G pic.twitter.com/3XyKt6P6wv
— ERAS Society (@ErasSociety) February 21, 2021
Current use of inotropes in circulatory shock
21 Feb, 2021 | 21:34h | UTCCurrent use of inotropes in circulatory shock – Annals of Intensive Care
Study: In intensively treated hypertensive patients, a diastolic blood pressure of less than 60 mm Hg was associated with increased risk of cardiovascular events
19 Feb, 2021 | 02:37h | UTCCommentary: Treated Diastolic Blood Pressure: How Low Is Too Low? – NEJM Journal Watch
Commentary on Twitter
Cohort study showed on-treatment diastolic BP <60 was associated with increased risk of adverse outcomes; on-treatment diastolic BP of 70-80 was associated with lowest adverse outcome risk in patients with on-treatment systolic BP <130 mmHg. @MayoClinic https://t.co/0wOfqpMcIH
— JAMA Network Open (@JAMANetworkOpen) February 17, 2021
Voices in Cardiology: How feeling like an imposter can impede your success
19 Feb, 2021 | 02:26h | UTCHow Feeling Like an Imposter Can Impede Your Success – JACC: Case Reports
BRUGADA-RISK: A primary prevention clinical risk score model for patients with Brugada Syndrome
18 Feb, 2021 | 02:57h | UTCCommentary: Risk Score Model for Brugada Syndrome – American College of Cardiology
A small, randomized cross-over trial showed Ivabradine may be a useful medication for hyperadrenergic POTS (Postural orthostatic tachycardia syndrome)
18 Feb, 2021 | 02:56h | UTCRandomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome – Journal of the American Academy of Cardiology (link to abstract – $ for full-text)
Commentaries: Existing heart failure drug may treat potential COVID-19 long-hauler symptom, study suggests – University of California – San Diego AND Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome – Ivabradine in POTS – American College of Cardiology
Commentary on Twitter
Our study showing ivabradine's benefit for POTS patients is out @JACCJournals. Also has implications for post-COVID 19 POTS (part of long haulers syndrome). Congrats to my co-first author/mentee @AdenaZadourian and the rest of my research team. @Dysautonomia @NIH @UCSDHealth pic.twitter.com/KGtzFh9CnT
— Pam R. Taub, MD (@PamTaubMD) February 15, 2021
Patient characteristics and clinical outcomes of Type 1 vs. Type 2 myocardial infarction
18 Feb, 2021 | 02:54h | UTCPatient Characteristics and Clinical Outcomes of Type 1 Versus Type 2 Myocardial Infarction – Journal of the American Academy of Cardiology (link to abstract – $ for full-text)
Commentary on Twitter
What are the patient characteristics & clinical outcomes of type 1 vs type 2 #cvMI in the U.S.? Over 200K+ are analyzed. Find out in this week’s issue of #JACC: https://t.co/trgZtKgbOy @CianPMcCarthy @mvaduganathan @JJheart_doc #HFWeek2021 #HeartMonth #CardioTwitter pic.twitter.com/dCdinfeNwE
— JACC Journals (@JACCJournals) February 16, 2021
Short review: Acute CV complications of hematopoietic stem cell transplantation
18 Feb, 2021 | 02:40h | UTCAcute CV Complications of Hematopoietic Stem Cell Transplantation – American College of Cardiology
European position paper on the management of patients with patent foramen ovale. Part II – Decompression sickness, migraine, arterial deoxygenation syndromes, and select high-risk clinical conditions
18 Feb, 2021 | 02:36h | UTC
Cardiac arrest in COVID-19: characteristics and outcomes of in- and out-of-hospital cardiac arrest
17 Feb, 2021 | 01:32h | UTC
Commentary on Twitter
#COVID19 was involved in at least 10% of all out-of-hospital cardiac arrests (OHCA) and 16% of intra-hospital cardiac arrests (IHCA) and, among #COVID_19 cases, 30-day mortality was increased 3.4-fold in OHCA & 2.3-fold in IHCA https://t.co/uS6rzTXuew#EHJ #ESCYoung @ehj_ed pic.twitter.com/QisuU9rsLT
— European Society of Cardiology Journals (@ESC_Journals) February 5, 2021